LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Actinium Pharmaceuticals Inc

Avatud

1.8 8.43

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.62

Max

1.84

Põhinäitajad

By Trading Economics

Sissetulek

-9.3M

-16M

Aktsiakasum

-0.51

Töötajad

31

EBITDA

-9.3M

-17M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+255.03% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

1. aug 2025

Turustatistika

By TradingEconomics

Turukapital

2.2M

51M

Eelmine avamishind

-6.63

Eelmine sulgemishind

1.8

Actinium Pharmaceuticals Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. juuni 2025, 20:45 UTC

Tulu

Broadcom 2Q Sales Climb on Booming AI Demand

5. juuni 2025, 23:45 UTC

Market Talk

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5. juuni 2025, 23:44 UTC

Market Talk

Gold Edges Higher on Weak U.S. Data -- Market Talk

5. juuni 2025, 23:30 UTC

Market Talk

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5. juuni 2025, 21:32 UTC

Tulu

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. juuni 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

5. juuni 2025, 20:45 UTC

Tulu

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. juuni 2025, 20:24 UTC

Tulu

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q Rev $15B >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q Net $4.97B >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q Adj EPS $1.58 >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q EPS $1.03 >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom Sees 3Q Rev $15.8B >AVGO

5. juuni 2025, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5. juuni 2025, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5. juuni 2025, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5. juuni 2025, 19:22 UTC

Market Talk

Oil Futures Resume Upward Moves -- Market Talk

5. juuni 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5. juuni 2025, 18:32 UTC

Market Talk

Gold Slips After Trump-Xi Call -- Market Talk

5. juuni 2025, 18:26 UTC

Tulu

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5. juuni 2025, 18:06 UTC

Market Talk

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5. juuni 2025, 16:30 UTC

Omandamised, ülevõtmised, äriostud

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5. juuni 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

5. juuni 2025, 16:18 UTC

Market Talk

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5. juuni 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

5. juuni 2025, 16:12 UTC

Market Talk

Global Energy Roundup: Market Talk

5. juuni 2025, 16:12 UTC

Market Talk

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5. juuni 2025, 16:03 UTC

Market Talk

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5. juuni 2025, 15:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Actinium Pharmaceuticals Inc Prognoos

Hinnasiht

By TipRanks

255.03% tõus

12 kuu keskmine prognoos

Keskmine 6 USD  255.03%

Kõrge 9 USD

Madal 4 USD

Põhineb 3 Wall Streeti analüütiku instrumendi Actinium Pharmaceuticals Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

3

Osta

0

Hoia

0

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. Its Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia (r/r AML). The company focuses on advancing its development for product candidate Actimab-A, a therapeutic agent that has demonstrated potential activity in r/r AML patients. In addition, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies. Its Iomab-ACT, a next generation conditioning candidate, is being developed for improving patient access and outcomes for curative cell and gene therapies. Further, the company's research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company holds approximately 235 patents and patent applications, including various patents related to the manufacture of the isotope Ac-225 in a cyclotron. The company is based in New York, New York.